Your browser doesn't support javascript.
loading
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial.
Landovitz, Raphael J; Hanscom, Brett S; Clement, Meredith E; Tran, Ha V; Kallas, Esper G; Magnus, Manya; Sued, Omar; Sanchez, Jorge; Scott, Hyman; Eron, Joe J; Del Rio, Carlos; Fields, Sheldon D; Marzinke, Mark A; Eshleman, Susan H; Donnell, Deborah; Spinelli, Matthew A; Kofron, Ryan M; Berman, Richard; Piwowar-Manning, Estelle M; Richardson, Paul A; Sullivan, Philip A; Lucas, Jonathan P; Anderson, Peter L; Hendrix, Craig W; Adeyeye, Adeola; Rooney, James F; Rinehart, Alex R; Cohen, Myron S; McCauley, Marybeth; Grinsztejn, Beatriz.
Afiliación
  • Landovitz RJ; Center for Clinical AIDS Research and Education, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: rlandovitz@mednet.ucla.edu.
  • Hanscom BS; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Clement ME; Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  • Tran HV; Department of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kallas EG; Department of Parasitic and Infectious Diseases, School of Medicine, University of Sao Paulo, Sao Paulo, Brazil.
  • Magnus M; Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
  • Sued O; Fundación Huésped, Buenos Aires, Argentina.
  • Sanchez J; Centro de Investigaciones Tecnologicas, Biomedicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Scott H; San Francisco Department of Public Health, San Francisco, CA, USA.
  • Eron JJ; Department of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Del Rio C; Emory University School of Medicine and Grady Health System, Atlanta, GA, USA.
  • Fields SD; Ross and Carol Nese College of Nursing, Pennsylvania State University, University Park, PA, USA.
  • Marzinke MA; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Eshleman SH; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Donnell D; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Spinelli MA; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Kofron RM; Center for Clinical AIDS Research and Education, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Berman R; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Piwowar-Manning EM; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Richardson PA; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Sullivan PA; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lucas JP; FHI 360, Durham, NC, USA.
  • Anderson PL; Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Aurora, CO, USA.
  • Hendrix CW; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Adeyeye A; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Rooney JF; Gilead Sciences, Foster City, CA, USA.
  • Rinehart AR; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Cohen MS; Department of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • McCauley M; FHI 360, Durham, NC, USA.
  • Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil.
Lancet HIV ; 10(12): e767-e778, 2023 12.
Article en En | MEDLINE | ID: mdl-37952550
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Síndrome de Inmunodeficiencia Adquirida / VIH-1 / Fármacos Anti-VIH / Personas Transgénero / Profilaxis Pre-Exposición Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Lancet HIV Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Síndrome de Inmunodeficiencia Adquirida / VIH-1 / Fármacos Anti-VIH / Personas Transgénero / Profilaxis Pre-Exposición Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Lancet HIV Año: 2023 Tipo del documento: Article